The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization

被引：0
|
作者：
Veelken, Rhea [1 ]
Olbrich, Anne [1 ]
Lieb, Sabine [1 ]
Schindler, Aaron [1 ]
Herber, Adam [1 ]
Ebel, Sebastian [2 ]
Denecke, Timm [2 ]
Berg, Thomas [1 ]
van Bommel, Florian [1 ]
机构：
[1] Univ Hosp Leipzig, Div Hepatol, Dept Med 2, Leipzig, Germany
[2] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-501-YI
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
    Zhong, Bin-Yan
    Yan, Zhi-Ping
    Sun, Jun-Hui
    Zhang, Lei
    Hou, Zhong-Heng
    Zhu, Xiao-Li
    Wen, Ling
    Ni, Cai-Fang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [22] Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Cho, Yun Ku
    Chung, Jin Wook
    Kim, Jae Kyun
    Ahn, Yong Sik
    Kim, Mi Young
    Park, Yoon Ok
    Kim, Wan Tae
    Byun, Jong Hoon
    CANCER, 2008, 112 (02) : 352 - 361
  • [23] Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Sohn, Won
    Ham, Cheol Bae
    Kim, Nam Hee
    Kim, Hong Joo
    Cho, Yong Kyun
    Jeon, Woo Kyu
    Kim, Byung Ik
    PLOS ONE, 2020, 15 (12):
  • [24] Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lin, Han-Chieh
    Lee, Rheun-Chuan
    Chiou, Yi-You
    Huo, Teh-Ia
    Lee, Shou-Dong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (10) : 1581 - 1588
  • [25] Prognostic Significance of Tumor Characteristics in Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma
    Abdalla, Abubaker
    Taha, Wesam
    Abdellatief, Amro
    Burton, M. Caroline
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S567 - S568
  • [26] Reply to: "The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy"
    Scheiner, Bernhard
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2022, 76 (05) : 1233 - 1234
  • [27] Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease
    Kirstein, Martha M.
    Voigtlaender, Torsten
    Schweitzer, Nora
    Hinrichs, Jan B.
    Marquardt, Jens
    Woerns, Marcus-Alexander
    Kloeckner, Roman
    Fruendt, Thorben W.
    Ittrich, Harald
    Wacker, Frank
    Rodt, Thomas
    Manns, Michael P.
    Wege, Henning
    Weinmann, Arndt
    Vogel, Arndt
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (02) : 238 - 246
  • [28] A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Chang Liu
    Lei Li
    Wu-sheng Lu
    Hua Du
    Lu-nan Yan
    Tian-fu Wen
    Wu-ran Wei
    Li Jiang
    Ming-qing Xu
    BMC Cancer, 18
  • [29] A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Liu, Chang
    Li, Lei
    Lu, Wu-sheng
    Du, Hua
    Yan, Lu-nan
    Wen, Tian-fu
    Wei, Wu-ran
    Jiang, Li
    Xu, Ming-qing
    BMC CANCER, 2018, 18
  • [30] Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
    Ji, Suk Kyeong
    Cho, Yun Ku
    Ahn, Yong Sik
    Kim, Mi Young
    Park, Yoon Ok
    Kim, Jae Kyun
    Kim, Wan Tae
    KOREAN JOURNAL OF RADIOLOGY, 2008, 9 (06) : 534 - 540
12345